8-Hydroxy Quinaldine

8-Hydroxy Quinaldine

SCHEMBL2434060

Cc1cc(C)c(O)c(C)c1.Cc1ccc2cccc(O)c2n1.Cc1ccc2cccc(O)c2n1.[Al]

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 2/20 0.72
KDM4E B2RXH2 5/20 0.45
PLAU P00749 1/20 0.45
NCF1 P14598 1/20 0.45
KMT2A Q03164 7/20 0.44
OPRK1 P41145 1/20 0.44
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
HPGD P15428 1/20 0.44
ALOX12 P18054 1/20 0.44
CYP2C19 P33261 1/20 0.44
HIF1A Q16665 1/20 0.44
HSD17B10 Q99714 1/20 0.44
PARP1 P09874 1/20 0.43
RAB9A P51151 4/20 0.42
CCR1 P32246 1/20 0.42
CCR5 P51681 1/20 0.42
MEN1 O00255 5/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
8-Hydroxy Quinaldine SCHEMBL2429891 0.89 METAP2 (0.79) METAP2KDM4EPLAUNCF1KMT2A
8-Hydroxy Quinaldine SCHEMBL28154168 0.87 METAP2 (0.82) METAP2KDM4EPLAUNCF1KMT2A
8-Hydroxy Quinaldine SCHEMBL6037117 0.87 METAP2 (0.82) METAP2KDM4EPLAUNCF1KMT2A
8-Hydroxy Quinaldine SCHEMBL8609920 0.87 METAP2 (0.96) METAP2KDM4EPLAUNCF1KMT2A
8-Hydroxy Quinaldine SCHEMBL30295552 0.87 METAP2 (0.96) METAP2KDM4EPLAUNCF1KMT2A
8-Hydroxy Quinaldine SCHEMBL5089361 0.87 METAP2 (0.96) METAP2KDM4EPLAUNCF1KMT2A
8-Hydroxy Quinaldine SCHEMBL262742 0.87 METAP2 (0.96) METAP2KDM4EPLAUNCF1KMT2A
8-Hydroxy Quinaldine SCHEMBL546577 0.87 METAP2 (0.96) METAP2KDM4EPLAUNCF1KMT2A
8-Hydroxy Quinaldine SCHEMBL4304584 0.87 METAP2 (0.96) METAP2KDM4EPLAUNCF1KMT2A
8-Hydroxy Quinaldine SCHEMBL2433878 0.86 METAP2 (0.74) METAP2KDM4EPLAUNCF1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190214575-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE JNC CORPORATION (JP) 2019-07-11 US disclosed
US-9590182-B2 Benzofluorene compound, material for luminescent layer using said compound and organic electroluminescent device JNC CORPORATION (JP) 2017-03-07 US disclosed
US-9478750-B2 Anthracene derivative and organic electroluminescent element using the same JNC CORPORATION (JP) 2016-10-25 US disclosed
EP-2897184-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE JNC Corporation (JP) 2015-07-22 EP disclosed
US-20150097162-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE JNC CORPORATION (JP) 2015-04-09 US disclosed
US-20140319510-A1 BENZOFLUORENE COMPOUND, MATERIAL FOR LUMINESCENT LAYER USING SAID COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE JNC CORPORATION (JP) 2014-10-30 US disclosed
EP-1935919-B1 POLYMER CONTAINING SULFO GROUP AND ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THE POLYMER YAMAMOTO CHEMICALS INC (JP) 2012-09-05 EP disclosed
US-8012608-B2 Polymer containing sulfo group and organic electroluminescent element containing the polymer Yamamoto Chemcials, Inc. (JP) 2011-09-06 US disclosed
US-20090230851-A1 Polymer Containing Sulfo Group and Organic Electroluminescent Element Containing the Polymer MITSUI CHEMICALS, INC. (JP) 2009-09-17 US disclosed
US-20080160347-A1 Benzofluorene compound, emission materials and organic electroluminescent device JNC CORPORATION (JP) 2008-07-03 US disclosed
EP-1935919-A1 POLYMER CONTAINING SULFO GROUP AND ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THE POLYMER Mitsui Chemicals, Inc. (JP) 2008-06-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080160347-A1 Benzofluorene compound, emission materials and organic electroluminescent device LEF1, TRPA1, BRD8 METAP2 4227/4885KDM4E 1083/4885PLAU 4499/4885
US-20190214575-A1 MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE L1CAM, VDAC1, VDAC2 METAP2 2832/4885KDM4E 1253/4885PLAU 1668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.